Skip to main content
HairCited

아연 관련 안드로겐성 탈모증

A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.

총 49,138명의 참여자를 대상으로 한 29건의 연구(메타분석 1건, RCT 3건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dzinc\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

Research on zinc for androgenetic alopecia is mixed — while zinc is important for hair follicle health, supplementation alone has not been clearly shown to improve pattern hair loss.

  • Mixed results across 29 studies, including a meta-analysis showing inconsistent findings
  • Some studies find lower zinc in people with pattern hair loss, others do not
  • Zinc is usually studied as part of multi-ingredient formulas, making its individual contribution unclear
  • Supplementation may only help if a zinc deficiency is confirmed

Key Study Findings

animal study
Protective mechanisms of zinc and/or selenium supplementation against BPA-induced male and offspring reproductive toxicity: Insights …
Dose: zinc and/or selenium supplementation; doses not specified in abstract vs: Placebo 효과: None None
review
[Nutrition in improving sleep quality and fighting insomnia].
Dose: tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral vs: Placebo 효과: None None
cross-sectional study
Zinc Status in Kurdish Adults With Hair Loss.
Dose: None vs: Placebo 효과: None None
systematic_review
Micronutrients and Androgenetic Alopecia: A Systematic Review.
Dose: variable across included studies vs: Placebo 효과: vitamin B, D, iron, zinc deficiencies associated with increased AGA risk; supplementation showed pot None
in vitro study
Regulatory Effects of Thai Rice By-Product Extracts from Oryza sativa L. cv. Bue Bang 3 …
Dose: not specified vs: Placebo 효과: melanin production 130.18 ± 9.13% of control; NO secretion 1.43 ± 0.05 µM p > 0.05 (vs theophylline, no

Key Statistics

33

연구

49138

참여자

Mixed

A

등급

Referenced Papers

Molecular nutrition & … 2024 7 인용
International journal of … 2021 23 인용
Annales de dermatologie … 2021 4 인용
Journal of cosmetic … 2019 15 인용
Indian journal of … 2017 10 인용
Acta dermatovenerologica Croatica … 2016 6 인용
Annals of dermatology 2013 114 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
8-11 mg/day
hairloss:
15-30 mg/day

상한량: 40 mg/day

연구에서 사용된 용량

용량 기간 효과 N
zinc and/or selenium supplementation; doses not specified in abstract -- Positive --
None -- Positive --
tryptophan, carbohydrates, omega-3, vitamins (B6, B12, folate, niacin, D, C, beta-carotene), mineral -- Positive --
None -- Neutral --
variable across included studies -- Mixed --
not specified -- Positive --
Daily tablet (L-cystine, L-methionine, liposomal glutathione, zinc, copper, iron, selenium, ubidecar 24 weeks Positive 20
Topical lotion containing zinc and arginine (concentration not specified) 23 weeks Positive 40

권장 복용 시간: With meals to minimize stomach upset; separate from iron and calcium by 2 hours

Safety & Side Effects

보고된 부작용

  • Nausea and vomiting (especially on an empty stomach)
  • Metallic taste in the mouth
  • Copper depletion with chronic high-dose use
  • Headache and diarrhea

알려진 상호작용

  • Copper supplements (zinc inhibits copper absorption at doses >40 mg/day)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Penicillamine (zinc reduces absorption of this rheumatoid arthritis drug)

일일 최대 섭취 허용량: 40 mg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 아연 help with 안드로겐성 탈모증?
Based on 33 studies with 49,138 participants, there is strong evidence from multiple clinical trials that 아연 may support 안드로겐성 탈모증 management. Our evidence grade is A (Strong Evidence).
How much 아연 should I take for 안드로겐성 탈모증?
Studies have used various dosages. A commonly studied range is 8-11 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 아연?
Reported side effects may include Nausea and vomiting (especially on an empty stomach), Metallic taste in the mouth, Copper depletion with chronic high-dose use, Headache and diarrhea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 아연 and 안드로겐성 탈모증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 33 peer-reviewed studies with 49,138 total participants. The overall direction of effect is mixed.

References

  1. [1] Jing Ma et al.. Environ Int. 2026. Protective mechanisms of zinc and/or selenium supplementation against BPA-induced male and offspring reproductive toxicity: Insights from multiomics analysis. doi:10.1016/j.envint.2025.109975 PubMed
  2. [2] Geir Bjørklund et al.. Curr Med Chem. 2025. Minerals and Trace Elements: Key Protectors of Skin Health and Defenders against Skin Disorders. doi:10.2174/0109298673348175250214054101 PubMed
  3. [3] Michael Kenneth Lawson. Biomed Pharmacother. 2025. Copper-quercetin complexes: methods of study, relevance to cell death pathways, therapeutic applications. doi:10.1016/j.biopha.2025.118055 PubMed
  4. [4] Rosa M Ortega et al.. Nutr Hosp. 2025. [Nutrition in improving sleep quality and fighting insomnia]. doi:10.20960/nh.06090 PubMed
  5. [5] Ruilong Wang et al.. Mol Nutr Food Res. 2024. Micronutrients and Androgenetic Alopecia: A Systematic Review. doi:10.1002/mnfr.202400652 PubMed
  6. [6] Hivi Mahmoud et al.. Cureus. 2024. Zinc Status in Kurdish Adults With Hair Loss. doi:10.7759/cureus.67264 PubMed
  7. [7] Zhaowenbin Zhang et al.. Bioact Mater. 2023. A combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch. doi:10.1016/j.bioactmat.2022.12.007 PubMed
  8. [8] Yating Yang et al.. Theranostics. 2023. Curcumin-zinc framework encapsulated microneedle patch for promoting hair growth. doi:10.7150/thno.84118 PubMed
  9. [9] Warintorn Ruksiriwanich et al.. Plants (Basel). 2023. Regulatory Effects of Thai Rice By-Product Extracts from Oryza sativa L. cv. Bue Bang 3 CMU and Bue Bang 4 … doi:10.3390/plants12030653 PubMed
  10. [10] Michela Starace et al.. Ital J Dermatol Venerol. 2023. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic … doi:10.23736/S2784-8671.22.07416-3 PubMed
  11. [11] Yiwen Zhang et al.. Eur J Epidemiol. 2022. Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study. doi:10.1007/s10654-022-00922-0 PubMed
  12. [12] Julia Welzel et al.. J Cosmet Dermatol. 2022. Reduction of telogen rate and increase of hair density in androgenetic alopecia by a cosmetic product: Results of a randomized, … doi:10.1111/jocd.14158 PubMed
  13. [13] Noor Altooq et al.. Hum Nutr Metab. 2022. The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy. doi:10.1016/j.hnm.2022.200141 PubMed
  14. [14] Elizabeth J Klein et al.. JAAD Int. 2022. Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities. doi:10.1016/j.jdin.2022.08.013 PubMed
  15. [15] Hua-Ching Chang et al.. J Cosmet Dermatol. 2022. Association between serum zinc levels and androgenetic alopecia: a systematic review and meta-analysis. doi:10.1111/jocd.14564 PubMed
  16. [16] Mohammed Al Abadie et al.. Dermatol Reports. 2022. Possible relationship between poor skin disorders prognosis and serum zinc level: A narrative review. doi:10.4081/dr.2022.9512 PubMed
  17. [17] Alfredo Rossi et al.. Ital J Dermatol Venerol. 2022. A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study. doi:10.23736/S2784-8671.21.06915-7 PubMed
  18. [18] Katrice M Karanfilian et al.. Int J Dermatol. 2021. Erosive pustular dermatosis of the scalp: causes and treatments. doi:10.1111/ijd.14955 PubMed
  19. [19] F Poizeau et al.. Ann Dermatol Venereol. 2021. Vulvar Fordyce adenitis: A cohort of 45 women. doi:10.1016/j.annder.2021.04.001 PubMed
  20. [20] Irina N Kondrakhina et al.. Diagnostics (Basel). 2020. Plasma Zinc Levels in Males with Androgenetic Alopecia as Possible Predictors of the Subsequent Conservative Therapy's Effectiveness. doi:10.3390/diagnostics10050336 PubMed
  21. [21] Olakunle J Onaolapo et al.. Pharmacol Rep. 2020. Dietary zinc supplement militates against ketamine-induced behaviours by age-dependent modulation of oxidative stress and acetylcholinesterase activity in mice. doi:10.1007/s43440-019-00003-2 PubMed
  22. [22] Ludmila Ribeiro Pedrosa et al.. Skinmed. 2020. A Matched Case-Control Study of Zinc Levels in Androgenetic Alopecia and Alopecia Areata: Is There a Need to Do Routine … PubMed
  23. [23] Enrico Carmina et al.. J Clin Endocrinol Metab. 2019. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. doi:10.1210/jc.2018-02548 PubMed
  24. [24] Fatma Mohamed El-Esawy et al.. J Cosmet Dermatol. 2019. Serum biotin and zinc in male androgenetic alopecia. doi:10.1111/jocd.12865 PubMed
  25. [25] Samer A Dhaher et al.. Indian J Dermatol. 2018. Estimation of Zinc and Iron Levels in the Serum and Hair of Women with Androgenetic Alopecia: Case-control Study. doi:10.4103/ijd.IJD_624_16 PubMed
  26. [26] Dinesh Gowda et al.. Int J Trichology. 2017. Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study. doi:10.4103/ijt.ijt_48_16 PubMed
  27. [27] Mansour Siavash et al.. J Res Pharm Pract. 2017. Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: … doi:10.4103/jrpp.JRPP_17_17 PubMed
  28. [28] Kumpol Aiempanakit et al.. Indian J Dermatol Venereol Leprol. 2017. Low plasma zinc levels in androgenetic alopecia. doi:10.4103/ijdvl.IJDVL_680_16 PubMed
  29. [29] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
  30. [30] Jana Zímová et al.. Acta Dermatovenerol Croat. 2016. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl. PubMed
  31. [31] Pedro Fong et al.. J Ethnopharmacol. 2015. In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss. doi:10.1016/j.jep.2015.10.005 PubMed
  32. [32] Perihan Ozturk et al.. J Trace Elem Med Biol. 2014. BMI and levels of zinc, copper in hair, serum and urine of Turkish male patients with androgenetic alopecia. doi:10.1016/j.jtemb.2014.03.003 PubMed
  33. [33] Shannon Famenini et al.. J Drugs Dermatol. 2014. Evidence for supplemental treatments in androgenetic alopecia. PubMed
  34. [34] Min Seong Kil et al.. Ann Dermatol. 2013. Analysis of serum zinc and copper concentrations in hair loss. doi:10.5021/ad.2013.25.4.405 PubMed
  35. [35] C Durusoy et al.. Clin Exp Dermatol. 2009. The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control … doi:10.1111/j.1365-2230.2008.03165.x PubMed
  36. [36] N V Tsiskarishvili et al.. Georgian Med News. 2007. [Effectiveness of the treatment plan for androgenetic alopecia]. PubMed
  37. [37] Leonid Benjamin Trost et al.. J Am Acad Dermatol. 2006. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. doi:10.1016/j.jaad.2005.11.1104 PubMed
  38. [38] C Piérard-Franchimont et al.. Int J Cosmet Sci. 2002. Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. doi:10.1046/j.1467-2494.2002.00145.x PubMed
  39. [39] F B De Waard-van der Spek et al.. Clin Exp Dermatol. 1989. Juvenile versus maturity-onset alopecia areata--a comparative retrospective clinical study. doi:10.1111/j.1365-2230.1989.tb02604.x PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.